Ximelagatran as a New Oral Anticoagulant for Thrombosis
Discovery of Ximelagatran in an Historical Perspective
Mechanism of Action of the Oral Direct Thrombin Inhibitor Ximelagatran
Pharmacokinetics and Pharmacodynamics of Ximelagatran
Low Potential for Interactions Between Melagatran/Ximelagatran and Other Drugs, Food, or Alcohol
A Step Change in Oral Anticoagulation
Ximelagatran for the Prevention of Venous Thromboembolism Following Elective Hip or Knee Replacement Surgery
Treating Patients with Venous Thromboembolism
Prevention of Stroke in Patients with Atrial Fibrillation
Prevention of Cardiovascular Events after Acute Coronary Syndrome
Ximelagatran in the Clinic
Review Questions